Strategies to reduce the risk of virus-related cancers

Annals of Oncology

Volumn 11, Issue 9, 2000, Pages 1091-1096

  Franceschi, S ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer; HBV; HCV; HIV; HPV; Vaccination; Viruses

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS CARCINOGENESIS; VIRUS CHARACTERIZATION; WART VIRUS;

ADULT; HUMAN; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; VACCINATION; VIRUS DISEASES;

EID: 0033789363     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008344502623     Document Type: Review

References (43)

1. Viruses in human cancers
2. The causes of cancer
3. The global health burden of infection associated cancers
4. DNA vaccines against cancer: From genes to therapy
5. Treatment options for chronic hepatitis. Antivirals look promising
6. Genital warts and cervical neoplasia: An epidemiological study
7. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
8. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide
9. Human papillomavirus infection and cervical cancer in Latin America
10. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain
11. Causes of cervical cancer in the Philippines: A case-control study
12. Preventing cervical cancer
13. Epidemiological evidence of an infective basis in childhood leukaemia
14. Urinary tract infection and risk of bladder cancer
15. Hepatitis C: The clinical spectrum of disease
16. The role of immune responses in the pathogenesis of hepatitis C virus infection
17. Hepatitis-C virus infection and cancer
18. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
19. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma
20. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma
21. Spectrum of AIDS-associated malignant disorders
22. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy
23. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
24. AIDS-related cancers in Africa: Maturation of the epidemic in Uganda
25. Risk of invasive cervical cancer among women with, or at risk for, HIV infection
26. Cancer death rates associated with human immunodeficiency virus infection in the United States
27. Human papillomavirus and cancer of the upper aerodigestive tract: A review of epidemiological and experimental evidence
28. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
29. Vaccination against infectious agents associated with human cancer
30. Hepatitis B vaccine efficacy at nine years of age following infant vaccination in the Gambia
31. The Gambia Hepatitis Intervention Study
32. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
33. Prevention of hepatocellular cancer: One of the most cost-effective ways to reduce adult mortality?
34. Hepatitis C vaccine hampered by viral complexity, many technical restraints
35. Accellerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
36. Immunization principles and vaccine use